147 related articles for article (PubMed ID: 36058996)
1. Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery.
Deloose K; Lansink W; Brodmann M; Werner M; Keirse K; Gouëffic Y; Verbist J; Maene L; Hendriks J; Brunet J; Ducasse E; Levent K; Sauguet A; Déglise S; Vandael F
Cardiovasc Intervent Radiol; 2022 Dec; 45(12):1855-1859. PubMed ID: 36058996
[TBL] [Abstract][Full Text] [Related]
2. Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions.
Deloose KR; Lansink W; Brodmann M; Werner M; Keirse K; Gouëffic Y; Verbist J; Maene L; Hendriks JMH; Brunet J; Ducasse E; Levent K; Sauguet A; Vandael F; Vercauteren S; Callaert J
JACC Cardiovasc Interv; 2023 Dec; 16(23):2900-2914. PubMed ID: 38092496
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
Laird JA; Schneider PA; Jaff MR; Brodmann M; Zeller T; Metzger DC; Krishnan P; Scheinert D; Micari A; Wang H; Masters M; Tepe G
Circ Cardiovasc Interv; 2019 Jun; 12(6):e007702. PubMed ID: 31195825
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Safety and Effectiveness of Paclitaxel Drug-Coated Balloons Alone or With Provisional Bare Metal Stenting for Real-World Femoropopliteal Lesions: IN.PACT Global Study Subgroup Analysis.
Ansel GM; Brodmann M; Rocha-Singh KJ; Menk JS; Zeller T;
Circ Cardiovasc Interv; 2024 Feb; 17(2):e013084. PubMed ID: 38348677
[TBL] [Abstract][Full Text] [Related]
5. Three-Year Results of the IN.PACT SFA Japan Trial Comparing Drug-Coated Balloons With Percutaneous Transluminal Angioplasty.
Soga Y; Iida O; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H
J Endovasc Ther; 2020 Dec; 27(6):946-955. PubMed ID: 32865145
[TBL] [Abstract][Full Text] [Related]
6. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes after paclitaxel-coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study.
Ko YG; Choi D; Rha SW; Won JH; Do YS; Lee SW; Menk JS; Kum S
Catheter Cardiovasc Interv; 2022 Dec; 100(7):1273-1283. PubMed ID: 36385562
[TBL] [Abstract][Full Text] [Related]
8. Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study.
Elmariah S; Ansel GM; Brodmann M; Doros G; Fuller S; Gray WA; Pinto DS; Rosenfield KA; Mauri L
Am Heart J; 2019 Mar; 209():88-96. PubMed ID: 30685679
[TBL] [Abstract][Full Text] [Related]
9. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.
Chen Z; Guo W; Jiang W; Wang F; Fu W; Zou Y; Deckers S; Li P; Popma JJ; Jaff MR
J Endovasc Ther; 2019 Aug; 26(4):471-478. PubMed ID: 31204595
[No Abstract] [Full Text] [Related]
10. Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study.
Brodmann M; Lansink W; Guetl K; Micari A; Menk J; Zeller T
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1276-1287. PubMed ID: 35864209
[TBL] [Abstract][Full Text] [Related]
11. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
13. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
Schneider PA; Laird JR; Tepe G; Brodmann M; Zeller T; Scheinert D; Metzger C; Micari A; Sachar R; Jaff MR; Wang H; Hasenbank MS; Krishnan P;
Circ Cardiovasc Interv; 2018 Jan; 11(1):e005891. PubMed ID: 29326153
[TBL] [Abstract][Full Text] [Related]
14. Real-World Clinical Outcomes of IN.PACT Admiral Drug-Coated Balloon for Femoropopliteal Artery Disease - 12-Month Results From Japan Post-Market Surveillance Study.
Soga Y; Iida O; Fujihara M; Kawasaki D; Saito S; Urasawa K; Yokoi H; Fernandez EJ; Guo J; Nakamura M;
Circ J; 2021 Nov; 85(12):2149-2156. PubMed ID: 34615815
[TBL] [Abstract][Full Text] [Related]
15. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
16. Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study.
Jia S; Liu J; Sun G; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
Ann Vasc Surg; 2022 May; 82():70-80. PubMed ID: 34902474
[TBL] [Abstract][Full Text] [Related]
17. Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).
Shishehbor MH; Zeller T; Werner M; Brodmann M; Parise H; Holden A; Lichtenberg M; Parikh SA; Kashyap VS; Pietras C; Tirziu D; Ardakani S; Beschorner U; Krishnan P; Niazi KA; Wali AU; Lansky AJ
Circulation; 2022 May; 145(22):1645-1654. PubMed ID: 35377157
[TBL] [Abstract][Full Text] [Related]
18. Total IN.PACT All-Subjects One-Year Analysis and Standard vs Broader Implications.
Kobe DS; Jaff MR; Zeller T; Schneider PA; Shishehbor MH
J Invasive Cardiol; 2020 Jul; 32(7):243-248. PubMed ID: 32610266
[TBL] [Abstract][Full Text] [Related]
19. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
Micari A; Brodmann M; Keirse K; Peeters P; Tepe G; Frost M; Wang H; Zeller T;
JACC Cardiovasc Interv; 2018 May; 11(10):945-953. PubMed ID: 29798770
[TBL] [Abstract][Full Text] [Related]
20. Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.
Deloose K; Bosiers M; Peeters P; Verbist J; Maene L; Beelen R; Keirse K; Hendriks J; Lauwers P; Wauters J; Verschueren M
J Endovasc Ther; 2020 Dec; 27(6):936-945. PubMed ID: 32873131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
